COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,233 Articles (22,733 medRxiv, 8,500 bioRxiv)

Most recent first Previous |  Page 1281: Articles 12801-12810  | Next

Yeast-expressed Recombinant SARS-CoV-2 Receptor Binding Domain, RBD203-N1 as a COVID-19 Protein Vaccine Candidate
Chen, W.-H., Pollet, J., Strych, U., Lee, J., Liu, Z., Kundu, R. T., Versteeg, L., Villar, M. J., Adhikari, R., Wei, J., Poveda, C., Keegan, B., Bailey, A. O., Chen, Y.-L., Gillespie, P. M., Kimata, J. T., Zhan, B., Hotez, P. J., Bottazzi, M. E.
10.1101/2021.08.24.457518 — Posted: 2021-08-25
Woodsmoke particulates alter expression of antiviral host response genes in human nasal epithelial cells infected with SARS-CoV-2 in a sex-dependent manner
Brocke, S. A., Billings, G. T., Taft-Benz, S. A., Alexis, N. E., Heise, M. T., Jaspers, I.
10.1101/2021.08.23.457411 — Posted: 2021-08-25
Direct RNA sequencing reveals SARS-CoV-2 m6A sites and possible differential DRACH motif methylation among variants
Campos, J. H., Maricato, J. T., Braconi, C. T., Antoneli, F., Janini, L. M. R., Briones, M. R.
10.1101/2021.08.24.457397 — Posted: 2021-08-25 Discussion: Onsite
Structure-based screening of drug candidates targeting the SARS-CoV-2 envelope protein
Xia, X., Zhang, Y., Li, S., Lin, H., Yan, Z.
10.1101/2021.08.25.457645 — Posted: 2021-08-25
Hydroxychloroquine for pre-exposure prophylaxis of COVID-19 in health care workers: a randomized, multicenter, placebo-controlled trial (HERO-HCQ)
Naggie, S., Milstone, A., Castro, M., Collins, S. P., Seetha, L., Anderson, D. J., Cahuayme-Zuniga, L., Batey-Turner, K., Cohen, L. W., Fraulo, E., Friedland, A., Garg, J., George, A., Mulder, H., Olson, R. E., O'Brien, E. C., Rothman, R. L., Shenkman, E., Shostak, J., Woods, C. W., Anstrom, K. J., Hernandez, A. F., HERO Research Program
10.1101/2021.08.19.21262275 — Posted: 2021-08-25
Discordant humoral and T cell immune responses to SARS-CoV-2 vaccination in people with multiple sclerosis on anti-CD20 therapy
Gadani, S. P., Reyes-Mantilla, M., Jank, L., Harris, S., Douglas, M., Smith, M. D., Calabresi, P. A., Mowry, E. M., Fitzgerald, K. C., Bhargava, P.
10.1101/2021.08.23.21262472 — Posted: 2021-08-25
Reduction in initiations of HIV treatment in South Africa during the COVID pandemic
Benade, M., Long, L., Rosen, S., Meyer-Rath, G., Tucker, J.-M., Miot, J.
10.1101/2021.08.18.21262046 — Posted: 2021-08-25
The impact of the COVID-19 pandemic on adult mental health in the UK: A rapid systematic review
Batteux, E., Taylor, J., Carter, H.
10.1101/2021.08.23.21262469 — Posted: 2021-08-25
Prioritizing COVID-19 vaccination efforts and dose allocation within Madagascar
Rasambainarivo, F., Ramiadantsoa, T., Raherinandrasana, A., Randrianarisoa, S., Rice, B. L., Evans, M. V., ROCHE, B., Randriatsrafara, F. M., Wesolowski, A., Metcalf, C. J. E.
10.1101/2021.08.23.21262463 — Posted: 2021-08-25
COVID-19 and Vitamin D (Co-VIVID Study): a systematic review and meta-analysis of randomized controlled trials
Varikasuvu, S. R., Thangappazham, B., Raj, H.
10.1101/2021.08.22.21262216 — Posted: 2021-08-25

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).